| Autor: |
Helen Lyall, Mary Campbell-Brown, James J. Walker |
| Rok vydání: |
1999 |
| Předmět: |
|
| Zdroj: |
Acta Obstetricia et Gynecologica Scandinavica. 78:340-345 |
| ISSN: |
0001-6349 |
| DOI: |
10.1034/j.1600-0412.1999.780413.x |
| Popis: |
Background. The study was an audit of patients who attended the Menstrual Disorders Clinic at Glasgow Royal Infirmary over a five year period, and received gonadotrophin-releasing hormone analog (GnRHa). We aimed to identify the clinical indications for the use of GnRHa, and the effect of the latter in terms of symptom resolution and ultimate outcome. We aim to use this information to formulate a strategy for the use of GnRHa by targeting this expensive therapy to those situations where maximum benefit will be achieved. Methods. A retrospective case review analysis of 201 patients. Results. Thirty-eight percent of women presented with pelvic pain, 33% with disordered menstruation and 26% with premenstrual symptomatology. Overall, 74% of patients reported a beneficial effect of GnRHa. In the non-cyclical pelvic pain group, those patients with adhesions constituted a much greater proportion of those who did not derive benefit from GnRHa than those who did (43% vs. 16%; p |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
